Trial intelligence / Profile preview

Celecoxib with Chemoradiation in Locally Advanced Head and Neck Cancer

NCT00603759Phase 3Unknown

Sponsor
Tehran University of Medical Sciences
Start
Apr 2006
Primary completion
Aug 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of celecoxib in head and neck cancer (HNC), sponsored by Tehran University of Medical Sciences. Status: unknown.

02

Drugs

celecoxib
03

Conditions

head and neck cancer (HNC)

Beyond the preview

Go deeper on NCT00603759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00603759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call